146 related articles for article (PubMed ID: 38190323)
1. Role of inter-alpha-trypsin inhibitor heavy chain 4 and its citrullinated form in experimental arthritis murine models.
Iwai T; Ohyama A; Osada A; Nishiyama T; Shimizu M; Miki H; Asashima H; Kondo Y; Tsuboi H; Mizuno S; Takahashi S; Ishigami A; Matsumoto I
Clin Exp Immunol; 2024 Feb; 215(3):302-312. PubMed ID: 38190323
[TBL] [Abstract][Full Text] [Related]
2. Citrullinated inter-alpha-trypsin inhibitor heavy chain 4 in arthritic joints and its potential effect in the neutrophil migration.
Osada A; Matsumoto I; Mikami N; Ohyama A; Kurata I; Kondo Y; Tsuboi H; Ishigami A; Sano Y; Arai T; Ise N; Sumida T
Clin Exp Immunol; 2021 Mar; 203(3):385-399. PubMed ID: 33238047
[TBL] [Abstract][Full Text] [Related]
3. Identification of novel biomarker as citrullinated inter-alpha-trypsin inhibitor heavy chain 4, specifically increased in sera with experimental and rheumatoid arthritis.
Kawaguchi H; Matsumoto I; Osada A; Kurata I; Ebe H; Tanaka Y; Inoue A; Umeda N; Kondo Y; Tsuboi H; Shinkai Y; Kumagai Y; Ishigami A; Sumida T
Arthritis Res Ther; 2018 Apr; 20(1):66. PubMed ID: 29636082
[TBL] [Abstract][Full Text] [Related]
4. Inter-alpha-trypsin inhibitor heavy chain 4: A serologic marker relating to disease risk, activity, and treatment outcomes of rheumatoid arthritis.
He K; He S; Su M
J Clin Lab Anal; 2022 Mar; 36(3):e24231. PubMed ID: 35064701
[TBL] [Abstract][Full Text] [Related]
5. Osteoblastic PLEKHO1 contributes to joint inflammation in rheumatoid arthritis.
He X; Liu J; Liang C; Badshah SA; Zheng K; Dang L; Guo B; Li D; Lu C; Guo Q; Fan D; Bian Y; Feng H; Xiao L; Pan X; Xiao C; Zhang B; Zhang G; Lu A
EBioMedicine; 2019 Mar; 41():538-555. PubMed ID: 30824383
[TBL] [Abstract][Full Text] [Related]
6. Milk Fat Globule-Epidermal Growth Factor 8 (MFG-E8) Is a Novel Anti-inflammatory Factor in Rheumatoid Arthritis in Mice and Humans.
Albus E; Sinningen K; Winzer M; Thiele S; Baschant U; Hannemann A; Fantana J; Tausche AK; Wallaschofski H; Nauck M; Völzke H; Grossklaus S; Chavakis T; Udey MC; Hofbauer LC; Rauner M
J Bone Miner Res; 2016 Mar; 31(3):596-605. PubMed ID: 26391522
[TBL] [Abstract][Full Text] [Related]
7. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
[TBL] [Abstract][Full Text] [Related]
8. c-Fms-mediated differentiation and priming of monocyte lineage cells play a central role in autoimmune arthritis.
Paniagua RT; Chang A; Mariano MM; Stein EA; Wang Q; Lindstrom TM; Sharpe O; Roscow C; Ho PP; Lee DM; Robinson WH
Arthritis Res Ther; 2010; 12(1):R32. PubMed ID: 20181277
[TBL] [Abstract][Full Text] [Related]
9. Citrullination of synovial proteins in murine models of rheumatoid arthritis.
Vossenaar ER; Nijenhuis S; Helsen MM; van der Heijden A; Senshu T; van den Berg WB; van Venrooij WJ; Joosten LA
Arthritis Rheum; 2003 Sep; 48(9):2489-500. PubMed ID: 13130468
[TBL] [Abstract][Full Text] [Related]
10. Endogenous myeloperoxidase is a mediator of joint inflammation and damage in experimental arthritis.
Odobasic D; Yang Y; Muljadi RC; O'Sullivan KM; Kao W; Smith M; Morand EF; Holdsworth SR
Arthritis Rheumatol; 2014 Apr; 66(4):907-17. PubMed ID: 24757143
[TBL] [Abstract][Full Text] [Related]
11. PAD4 is not essential for disease in the K/BxN murine autoantibody-mediated model of arthritis.
Rohrbach AS; Hemmers S; Arandjelovic S; Corr M; Mowen KA
Arthritis Res Ther; 2012 May; 14(3):R104. PubMed ID: 22551352
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal change of serum inter-alpha-trypsin inhibitor heavy chain H4, and its correlation with inflammation, multiorgan injury, and death risk in sepsis.
Zhao X; Guo Y; Li L; Li Y
J Clin Lab Anal; 2023 Feb; 37(3):e24834. PubMed ID: 36725250
[TBL] [Abstract][Full Text] [Related]
13. The impact of airborne endotoxin exposure on rheumatoid arthritis-related joint damage, autoantigen expression, autoimmunity, and lung disease.
Mikuls TR; Gaurav R; Thiele GM; England BR; Wolfe MG; Shaw BP; Bailey KL; Wyatt TA; Nelson AJ; Duryee MJ; Hunter CD; Wang D; Romberger DJ; Ascherman DP; Poole JA
Int Immunopharmacol; 2021 Nov; 100():108069. PubMed ID: 34461491
[TBL] [Abstract][Full Text] [Related]
14. Essential role of neutrophils in the initiation and progression of a murine model of rheumatoid arthritis.
Wipke BT; Allen PM
J Immunol; 2001 Aug; 167(3):1601-8. PubMed ID: 11466382
[TBL] [Abstract][Full Text] [Related]
15. Modulation of Neutrophil Function by Recombinant Human IgG1 Fc Hexamer in the Endogenous K/BxN Mouse Model of Rheumatoid Arthritis.
Almizraq RJ; Frias Boligan K; Lewis BJB; Cen S; Whetstone H; Spirig R; Käsermann F; Campbell IK; von Gunten S; Branch DR
Pharmacology; 2023; 108(2):176-187. PubMed ID: 36696888
[TBL] [Abstract][Full Text] [Related]
16. IL-17 increases cadherin-11 expression in a model of autoimmune experimental arthritis and in rheumatoid arthritis.
Park YE; Woo YJ; Park SH; Moon YM; Oh HJ; Kim JI; Jin HS; Baek SH; Kim GT; Lee JH; Cho ML; Kim SI
Immunol Lett; 2011 Oct; 140(1-2):97-103. PubMed ID: 21798287
[TBL] [Abstract][Full Text] [Related]
17. Serum inter-alpha-trypsin inhibitor heavy chain 4 in patients with inflammatory bowel disease: correlation with disease risk, inflammation, activity, and its variation after treatment.
Wen N; Zhao N; Xu H; Zhao Y; Ma J
Ir J Med Sci; 2022 Oct; 191(5):2105-2111. PubMed ID: 34843071
[TBL] [Abstract][Full Text] [Related]
18. A citrullinated fibrinogen-specific T cell line enhances autoimmune arthritis in a mouse model of rheumatoid arthritis.
Cordova KN; Willis VC; Haskins K; Holers VM
J Immunol; 2013 Feb; 190(4):1457-65. PubMed ID: 23319740
[TBL] [Abstract][Full Text] [Related]
19. Kinetic analysis of synovial signalling and gene expression in animal models of arthritis.
Fukushima A; Boyle DL; Corr M; Firestein GS
Ann Rheum Dis; 2010 May; 69(5):918-23. PubMed ID: 19473996
[TBL] [Abstract][Full Text] [Related]
20. TIARP attenuates autoantibody-mediated arthritis via the suppression of neutrophil migration by reducing CXCL2/CXCR2 and IL-6 expression.
Inoue A; Matsumoto I; Tanaka Y; Umeda N; Takai C; Kawaguchi H; Ebe H; Yoshida H; Matsumoto Y; Segawa S; Takahashi S; Sumida T
Sci Rep; 2016 Dec; 6():38684. PubMed ID: 27995997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
